Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891317 · ClinicalTrials.gov registry record
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02891317: Clinical Trial study, sponsored by University of North Carolina, Chapel Hill.
NCT02891317 is a clinical trial that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02891317 was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how surgical interventions in glaucoma affect 24-hour intraocular pressure, 24-hour ocular perfusion pressure, optic nerve blood flow, and retinal oxygen saturation.
Primary Outcome
Trends in 24 hr IOP will be assessed using the Triggerfish contact lens system. Subjects will wear the lens on the surgical eye before and after surgery. Intraday and nocturnal trends will be analyzed. Additionally, ocular biometric measurements will be acquired and used in conjunction with the Triggerfish lens to develop a conversion factor for Triggerfish measurements (mV Eq) to intraocular pressure measurements (mmHg).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2017-06-12 |
Why NCT02891317 stopped before completion
NCT02891317 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02891317 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02891317 about?
NCT02891317 is a clinical study titled "Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma". The purpose of this study is to assess how surgical interventions in glaucoma affect 24-hour intraocular pressure, 24-hour ocular perfusion pressure, optic nerve blood flow, and retinal oxygen saturation.
What is the current status of trial NCT02891317?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-05-08. Estimated completion is 2017-06-12.
Who is sponsoring clinical trial NCT02891317?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI